연구동향 분석

Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them

Amábile-Cuevas Carlos F. 2022년

논문상세정보
인용/피인용
' Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Antibiotic R&D
  • Antibiotic resistance
  • Antibiotic usage
  • Generic antibiotics
  • Treatment adherence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
77 0

0.0%

' Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them' 의 참고문헌

  • Why are antibiotic resistance genes so resistant to elimination?
    Salyers AA [1997]
  • The new antibiotic mantra-"shorter is better"
    Spellberg B [2016]
  • The microbial genetics of antibiotic cycling
    John JF Jr [2000]
  • The maturing antibiotic mantra : "Shorter is still better"
    Spellberg B [2018]
  • The fitness costs of antibiotic resistance mutations
  • The antibiotic course has had its day
    Llewelyn MJ [2017]
  • Tackling drug-resistant infections globally: Final report and recommendations
    O’Neil J [2016]
  • Systematic review of the effects of antimicrobial cycling on bacterial resistance rates within hospital settings
  • Superbugs in the anthropocene : A profit-driven plage
    Angus I [2019]
  • Substandard drugs : a potential crisis for public health
    Johnston A [2014]
  • Speeding new antibiotics to market: a fake fix?
    Doshi P [2015]
  • Society must seize control of the antibiotics crisis
  • Shooting the messenger of antibiotic resistance : plasmid elimination as a potential counter-evolutionary tactic
  • Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut
    Bakkeren E [2019]
  • Robust Salmonella metabolism limits possibilities for new antimicrobials
    Becker D [2006]
  • Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections
    Chung H [2022]
  • Profitability of large pharmaceutical companies compared with other large public companies
    Ledley FD [2020]
  • Plasmid persistence : costs, benefits, and the plasmid paradox
    Carroll AC [2018]
  • Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin
    Lambert PA [2003]
  • Pharmaceutical pollution of the world’s rivers
  • Phage therapies : Lessons(not)learned from the"antibiotic era"
  • Persistence and reversal of plasmidmediated antibiotic resistance
    Lopatkin AJ [2017]
  • Past and present perspectives on β-lactamases
    Bush K [2018]
  • Origin and molecular evolution of the determinant of methicillin resistance in staphylococci
  • On the exoneration of Dr. William H. Stewart : debunking an urban legend
    Spellberg B [2013]
  • Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
    Sandegren L [2008]
  • Multiple drug resistant bacteria
    Fraimow HS [2003]
  • More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA
    Jones RN [2013]
  • Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
    Sundqvist M [2010]
  • Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes
    Johnson EO [2019]
  • Knowing when to stop antibiotic therapy
    Gilbert GL [2015]
  • Issues beyond resistance : inadequate antibiotic therapy and bacterial hypervirulence
    Goneau LW [2020]
  • In vitro and in vivo comparison of the antistaphylococcal efficacy of generic products and the innovator of oxacillin
  • Impact on bacterial resistance of therapeutically nonequivalent generics : The case of piperacillin-tazobactam
  • Hetero-resistance : an under-recognised confounder in diagnosis and therapy?
    Rinder H [2001]
  • Gross national income and antibiotic resistance in invasive isolates : analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list
    Savoldi A [2019]
  • Global trends in antimicrobial use in food animals
  • Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
    Klein EY [2018]
  • Global burden of bacterial antimicrobial resistance in 2019 : a systematic analysis
  • Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator
    Vesga O [2010]
  • Generic antibiotics, antibiotic resistance, and drug licensing
    Finch R [2010]
  • Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus
    Foucault ML [2009]
  • Extremely and pandrug-resistant bacteria extradeaths : myth or reality?
    Abat C [2018]
  • Exposure to one antibiotic leads to acquisition of resistance to another antibiotic via quorum sensing mechanisms
    Shu CC [2021]
  • Exploiting quorum sensing to confuse bacterial pathogens
    LaSarre B [2013]
  • Evolution of resistance to quorum-sensing inhibitors
    Kalia VC [2014]
  • Evolution of a bacteria/plasmid association
    Bouma JE [1988]
  • Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence : the case of meropenem
    Agudelo M [2014]
  • Effect of generics on price and consumption of ciprofloxacin in primary healthcare : the relationship to increasing resistance
    Jensen US [2010]
  • Ecostorm. Superbugs in the supply chain: How pollution from antibiotics factories in India and China is fueling the global rise of drug-resistant infections
  • Do antibiotics maintain antibiotic resistance?
  • Cycling antibiotics may not be good for your health
    Levin BR [2004]
  • Cross-border antibiotic resistance patterns in trauma patients
  • Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
    Duan Y [2019]
  • Bacterial virulence as a target for antimicrobial chemotherapy
    Alksne LE [2000]
  • Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
    Oliver A [2010]
  • Assessment of antibiotic use and concordance with practice guidelines within 3 diverse ambulatory clinic systems
    Sohn M [2020]
  • Antimicrobial resistance in developing countries
  • Antimicrobial resistance in developing countries
    Newton PN [2010]
  • Antimicrobial resistance associations with national primary care antibiotic stewardship policy : Primary care-based, multilevel analytic study
    Hammond A [2020]
  • Antimicrobial resistance : the major contribution of poor governance and corruption to this growing problem
    Collignon P [2015]
  • Antimicrobial pharmacodynamics in theory and clinical practice
    Craig WA [2002]
  • Antimicrobial drug use and resistance in Europe
  • Antibiotics and antibiotic resistance in the environment
  • Antibiotics : combatting tolerance to stop resistance
    Windels EM [2019]
  • Antibiotic usage and resistance in Mexico : an update after a decade of change
  • Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes
    Albrich WC [2004]
  • Antibiotic resistance is ancient
  • Antibiotic resistance in oral commensal streptococci from healthy Mexicans and Cubans : resistance prevalence does not mirror antibiotic usage
  • Antibiotic resistance from, and to the environment
  • Antibiotic resistance : from Darwin to Lederberg to Keynes
  • Antibiotic cycling or rotation : a systematic review of the evidence of efficacy
    Brown EM [2005]
  • Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria
  • Alternatives to antibiotics-a pipeline portfolio review
  • A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
    Suda KJ [2013]
  • A multivariable analysis of the contribution of socioeconomic and environmental factors to blood culture Escherichia Coli resistant to fluoroquinolones in high-and middle-income countries
    Booth A [2022]
  • "Ten commandments"for the appropriate use of antibiotics by the practicing physician in an outpatient setting
    Levy-Hara G [2011]